Navigation Links
Invuity Bolsters Executive Team; Adds Industry Veterans in Key Finance and Commercial Roles
Date:2/13/2013

SAN FRANCISCO, Feb. 13, 2013 /PRNewswire/ -- Invuity, a leading developer of advanced visualization devices for minimally invasive surgery, announced that it has named Michael J. Gandy as Chief Financial Officer and Robert E. Gerberich as Vice President, Sales & Marketing.  Both have more than two decades of experience in the medical device industry and will report directly to Invuity CEO Philip Sawyer .

"We have reached a key point in our corporate and commercial development where it is critical to expand our executive team. Both Mike and Bob bring extensive industry experience combined with a strategic mindset and strong leadership to Invuity's dynamic organization," Sawyer commented. "2013 will be a notable year at Invuity as we launch novel new products, build out the company's infrastructure and capitalize on the rapid growth we are experiencing in our initial markets.  Our strengthened executive team will refine and execute the strategies to establish our proprietary Eigr™ (pronounced eye-gr) technology as a true platform technology – capable of driving growth across multiple surgical specialties and enabling new minimally invasive and minimal access surgical techniques to improve patient outcomes."

Gandy has spent more than 20 years leading the finance and accounting teams at both private and publicly traded medical technology companies.  He came to Invuity from Newark, CA-based Novasys Medical, Inc., a medical device company focused on women's health, where he served as CFO.  Prior to Novasys, Gandy served as CFO at Baxano, Inc., a San Jose-based spinal device company, where he had broad functional responsibility for finance and accounting, including oversight of venture funding activities.  Gandy also served as Vice President, Finance and CFO at privately held Bacchus Vascular, leading the finance and accounting groups leading up to the successful acquisition of the company by Covidian in 2009. Prior to that role, he held positions in financial management at a number of private and public companies, including nine years of increasing financial management at a division of NYSE-traded Guidant Corporation.

Gerberich has served in sales and marketing leadership roles for two decades within the surgical device and medical aesthetics segments of the life sciences market. He comes to Invuity from Dallas-based Primcogent Solutions, Inc., where he served as Senior Vice President of Global Sales and Field Development leading the commercialization of innovative low-level laser therapy (LLLT) technologies. Prior to that, Gerberich spent six years as President of San Ramon, CA-based UltraShape NA Inc. and head of global sales for Israel-based UltraShape Ltd. (acquired by Syneron Medical Ltd.) where he launched the first non-surgical focused ultrasound body sculpting technology. Gerberich also served as VP Marketing and Sales at Hayward, CA-based Thermage, Inc. (now Solta Medical) where he was responsible for launching the first non-invasive radiofrequency tissue tightening technology and led the effort in building sales from zero to $50 million.  He also led dynamic and fast growing sales organizations at several other medical device companies representative of Invuity's target markets.

"Mike and Bob bring a wealth of experience to Invuity, and we are delighted to have them on board to complement the rest of our talented executive team," commented Philip Sawyer .

About Eigr™
Eigr Technology combines injection-molded optical lens waveguide technology with integrated microstructures to control illumination output to the operative space. Eigr projects thermally cool, brilliant white light broadly and uniformly within the deepest darkest surgical cavities to provide unsurpassed visualization while virtually eliminating shadows, back reflection, glare and thermal hazards.

About Invuity
Invuity develops advanced medical devices to dramatically improve access and visualization in minimally invasive and minimal access surgeries. The company's products incorporate its proprietary Eigr™ technology into sophisticated hand-held illumination devices and illuminated access systems for a variety of surgical specialties including spine, orthopedics, breast and thyroid oncology and plastic surgery. The company is headquartered in San Francisco, CA. For more information, visit www.invuity.com.


'/>"/>
SOURCE Invuity
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Hello Health Inc. Names Barry Holleman Executive Vice President, Chief Operating Officer
2. Uroplasty Announces Executive Changes In US Sales Organization
3. Alliqua Strengthens and Realigns Executive Team
4. Lilly Recognized for Fifth Straight Year on NAFEs Top 50 Companies for Executive Women
5. H. D. Smith Specialty Solutions Appoints 20-year Industry Veteran Tim Booth To Executive Vice President, Smith Medical Partners
6. MGC Diagnostics Corporation Appoints Wesley W. Winnekins as Executive Vice President, Finance and Corporate Development; Winnekins will also serve as Chief Financial Officer
7. Synteract Appoints Keith Kelson as Chief Financial Officer and Member of Executive Council and Philip Doren, Ph.D., as Vice President, Biometrics
8. Amedica Announces Expansion Of Executive Team
9. Marketers Unite with Focus on Increasing Digital Marketing Influence to Executives
10. Executives guide entrepreneurs through science business maze
11. Choice Logistics Executive Doug Magnan to Chair Field Service Medical in San Diego
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... DURHAM, N.C. , Feb. 8, 2016  Avista ... appointed Eric Setzer as Chief Financial Officer (CFO). ... over twenty years of experience in various roles within ... Avista Pharma, he served as the Executive Director of ... organization in Raleigh, NC . Previously, ...
(Date:2/8/2016)...  HemaFlo Therapeutics, Inc. announced today that the United States ... 9,119,880 covering the use of NephroFlow to treat acute kidney ... founder, said, "We are pleased to secure our rights to ... , PhD, HemaFlo,s founder, said, "We are pleased to secure ... Dale Peterson , PhD, HemaFlo,s founder, said, "We ...
(Date:2/8/2016)... 2016 Palatin Technologies, Inc. (NYSE MKT: ... therapeutics for the treatment of diseases with significant ... that the United States Patent and Trademark Office ... U.S. Patent Application Serial Number 14/313,258 (the ,258 ... treating female sexual dysfunction using the formulation and ...
Breaking Medicine Technology:
(Date:2/8/2016)... ... February 08, 2016 , ... GrassrootsHealth ... incidence rate of type 2 diabetes in the GrassrootsHealth cohort with substantially higher ... make a change in public health,” states Carole Baggerly, Director of GrassrootsHealth, “the ...
(Date:2/8/2016)... Las Vegas, Nevada (PRWEB) , ... February 08, ... ... Co-Founder at RowdMap, Inc., will be speaking on how healthcare companies can use ... project costs, manage the health of a population and intervene and capture the ...
(Date:2/8/2016)... ... February 08, 2016 , ... According to research by ... require dental technicians to be certified or obtain continuing education. To increase patient ... “What’s In Your Mouth?” campaign to inform dentists and patients about the possible ...
(Date:2/7/2016)... ... February 07, 2016 , ... ... MyDecision™ empowers employers and organizations with the tools and information to lower the ... elements to cut the cost of providing employee healthcare benefits by as much ...
(Date:2/6/2016)... ... ... US Sports Camps is proud to sponsor the Bay Area Disc Association's ... leaders, ultimate organizations, and coaches from around the US. The theme for this year’s ... of Youth and Education, describes this year YUCC as “an important conversation we must ...
Breaking Medicine News(10 mins):